Project Report for 100 Bed Hospital
Planning a 100-bed hospital entails more than just calculating building and equipment expenditures. Banks evaluate projects based on their financial viability, operational planning, revenue estimates, and payback capability. A strong hospital proposal should address main lender concerns with precise paperwork, realistic assumptions, and a clear business plan that translates a clinical goal into a financially feasible enterprise.
Get free Sample
The 5 Questions Your Bank Will Ask Before Funding It
Most guides on setting up a 100 bed hospital start with construction cost and equipment lists. That’s useful information, but it’s not what actually decides whether your hospital gets built — your bank’s credit committee decides that, and they don’t evaluate your proposal the way a hospital consultant does.
They evaluate it the way a lender does: through five specific questions, asked in a specific order, and if your documentation doesn’t answer all five convincingly, the money doesn’t move, no matter how good your clinical plan is.
That’s exactly the gap Sharda Associates was built to close. As a Bhopal-based CA and financial consultancy firm, the team has spent years sitting across the table from exactly this problem—a promoter with a strong clinical vision for a 100-bed hospital and a bank that needs to see that vision translated into numbers it can underwrite.
What follows isn’t a generic hospital-setup checklist; it’s the actual sequence of financial questions a bank works through, explained the way an experienced consultant would walk a client through it before the first meeting.
Question 1: "What Exactly Are We Financing?"
Before looking at a single rupee amount, a bank wants a clear image of the facility itself. A 100-bed hospital is not the same as a multi-specialty facility in a metro city with a cath lab and ICU wing; a secondary-care structure with the same bed count in a tier-2 town based around general medicine, obstetrics, and basic surgery looks very different financially. Banks have seen enough ambiguous proposals to recognize that “100 beds” without a clear specialized mix is sometimes a hint that the promoter has not completed their own planning yet.
This is where your bed-mix and specialty plan must be explicit: how many general ward beds, how many private rooms, how many ICU/critical care beds, whether you’re including an operating room count, and which specialties (general medicine, surgery, orthopedics, gynecology, pediatrics, and so on) you’re committing to at launch versus phasing in later. Several publicly available industry cost studies on hospital projects of this type focus on phase commissioning, which involves starting with a smaller functional core (often 30 beds) and gradually increasing to the full 100 bed capacity over 12-24 months, rather than opening all 100 beds simultaneously. Banks often respond positively to this phased approach since it decreases their risk exposure in year one.
Question 2: "Does the Investment Number Actually Add Up?"
This is where most promoter-prepared ideas fail—not because the total sum is incorrect, but because it is not broken down credibly. Cost studies for facilities of this scale range between ₹20 crore and ₹60 crore, with land cost, construction specification, and diagnostic and critical-care equipment included at launch largely driving the difference.
According to a government-linked feasibility study, the capital cost of a similar-sized hospital is approximately ₹11 crore for land and building, ₹10.5 crore for plant and machinery (medical equipment), and ₹2 crore for working capital for the first two months. This results in a total capital investment of ₹23-24 crore for that configuration, excluding land ownership premium in high-cost cities.
Your bank does not expect you to hit an exact number from a published study; instead, they expect you to build your own number in the same way: land/building, medical equipment, furniture and biomedical fit-out, pre-operative expenses, and working capital, each backed by an actual quotation rather than a round figure. A single unsupported lump payment is one of the quickest ways to get a proposal returned for revision
Cost Head | What It Typically Covers | Why Banks Check It Closely |
Land & building | Construction, civil work, or lease premium | Often 35-40% of total project cost — the single largest line item |
Medical equipment | Diagnostics, OT equipment, ICU monitoring, biomedical devices | Directly tied to your specialty mix — mismatched equipment plans raise flags |
Furniture & fit-out | Ward furniture, fixtures, interiors | Straightforward, but frequently underestimated by first-time promoters |
Pre-operative expenses | Licensing, consultancy, architectural fees | Small relative to total cost, but must be itemized, not bundled |
Staff salaries, consumables, utilities before revenue stabilizes | Banks want to see 2-3 months minimum covered, given a hospital’s inherently slow ramp-up to full occupancy |
Question 3: "Who's Actually Going to Pay the Bills, and When?"
A facility of this size does not fill up on the first day, and every bank that underwrites such loans understands this. What they actually want to know is how viable your occupancy ramp-up assumption is, and whether your revenue model really represents how Indian hospitals of this size normally break even.
Multiple independent industry sources agree on a similar pattern: a 100-bed hospital typically operates at partial capacity utilization for the first year or two, with breakeven falling somewhere between 24 and 60 months depending on payer mix, specialty positioning, and local competition — not the 12-month “hockey stick” projections that inexperienced business plans sometimes present. A bank who sees an unreasonably fast breakeven assumption interprets it as a promoter who has not stress-tested their own statistics, and it becomes a reason to request adjustments rather than approve.
Your payer mix is equally as important as your occupancy curve. Whether you’re targeting self-pay patients, insurance/TPA tie-ups, or government scheme empanelment (Ayushman Bharat/PMJAY, for example), your realistic pricing and collection timeline change — government scheme reimbursements, in particular, often follow a slower payment cycle than private insurance or self-pay, and this must be clearly reflected in your cash flow projection, not glossed over.
Question 4: "What Happens If This Loan Isn't Repaid on Schedule?"
This is where DSCR (Debt Service Coverage Ratio) comes into play, the single metric that most credit committees consider before anything else in a large-ticket loan file. It basically determines whether your predicted cash flow can comfortably satisfy your loan repayment requirement. Most banks like a ratio of around 1.25, which means that your available cash flow should exceed your payback commitment by at least 25%.
For a project of this size, DSCR calculation is not a side note; it is frequently the determining factor in the overall sanction. Because hospital revenue genuinely ramps up in stages (as occupancy grows, specialties come online, and payer relationships mature), your DSCR modeling must realistically reflect year-over-year improvement, typically supported by a longer initial moratorium period than a standard commercial loan, rather than assuming a flat, immediate repayment capacity from month 1. A financial plan that does not properly walk the bank through this year-by-year ramp-up is one of the most typical reasons large hospital loan files are postponed for modification rather than accepted outright.
Question 5: "Is This Documentation Something We Can Actually Defend to Our Own Credit Committee?"
Here’s an important fact about how bank lending works at this loan size: the relationship manager examining your file is rarely the final decision-maker. They must present your data to a credit committee, and their primary responsibility is to internally defend your proposition. A imprecise, inconsistent, or unprofessionally produced document not only risks rejection, but also puts the bank officer promoting your loan in a difficult position, which is why CA-certified documentation carries real, practical weight beyond simply “looking official.” When a Chartered Accountant’s certification, ICAI membership information, and signature are attached to your financial projections and DSCR calculations, the relationship manager has something concrete and believable to defend internally, as opposed to a document they must personally testify for.
This is genuinely the most common gap Sharda Associates sees when promoters approach the firm after a loan has already been delayed or sent back once: not a flawed business idea, but documentation that couldn’t survive the bank’s internal scrutiny process. A properly prepared business plan for this scale of facility typically includes a detailed executive summary, promoter background, specialty-wise revenue build-up, phase-wise capital deployment plan, multi-year P&L and cash flow projections, and a fully worked DSCR schedule — each section built to hold up not just to the branch manager reading it first, but to the credit committee reviewing it afterward.
Licenses and Regulatory Approvals You'll Need Alongside Financing
Financing approval and regulatory approval occur concurrently, and banks often want to see clear progress in both. For a facility of this size, expect to need a Clinical Establishment registration (mandatory under the Clinical Establishments Act in states where it’s adopted), fire safety and building-plan approval specific to healthcare facilities, biomedical waste management authorization, a pollution control NOC, radiology/X-ray equipment licensing (AERB approval) if you’re including imaging services, and — increasingly important for insurance/TPA and Ayushman Bharat empanelment
Financing Routes for a Project of This Scale
Route | Where It Fits |
Standard term loan (public/private sector bank) | The primary financing route given the scale typically involved — usually structured with a multi-year moratorium reflecting the occupancy ramp-up |
CGTMSE-backed loan | Relevant only if the facility structure and loan amount fit within MSME classification limits — worth confirming with your bank, since many 100 bed projects exceed typical MSME thresholds |
Syndicated/consortium lending | Common at this project size, where more than one bank shares the exposure |
State healthcare infrastructure incentives | Some states offer land or stamp duty concessions for healthcare facilities in underserved areas — worth checking regional applicability regardless of your financing route |
PMEGP, Mudra, and similar small-enterprise schemes generally don’t apply at this scale — a facility of this size sits well beyond their project cost ceilings, so it’s worth not spending planning time chasing schemes designed for much smaller ventures.
Frequently Asked Questions
According to published industry cost estimates, the overall project cost ranges from ₹20 crore to ₹60 crore, depending on land cost, construction specifications, and diagnostic/critical-care equipment included at launch. There is no single fixed amount; always create your own estimate using actual land, building, and equipment quotations.
Most industry sources estimate 18-24 months from initial planning to commissioning, but this varies depending on site acquisition status, building permissions, and whether you're phasing bed commissioning rather than launching all 100 beds at once.
The DSCR (Debt Service Coverage Ratio) determines if your forecasted cash flow easily meets your loan payback obligation. Most banks need a minimum of approximately 1.25, and for a large facility of this size, the DSCR calculation must accurately include a multi-year occupancy ramp-up rather than assuming immediate full repayment capacity.
Generally, no. These programs are intended for considerably smaller-ticket MSME funding and often do not fit a project of this size. At this level, the most viable funding option is a typical bank term loan, which is often organized as syndication between many lenders.
It is not required by law in all states, but it has become a practical requirement for insurance and TPA empanelment, and many payers, including government scheme empanelment, regard it as a true prerequisite rather than a choice.
Inconsistency in the paperwork, such as a specialized mix, cost breakdown, occupancy assumption, or DSCR calculation that does not reconcile cleanly throughout all sections of the report, is a far more prevalent cause of delay than an unsound underlying business plan.
Phased commissioning, which typically begins with a smaller functional core, such as 30 beds, and progresses to full 100 bed capacity over 12-24 months, is a widely recommended and bank-friendly approach because it reduces financial exposure during the critical first year while occupancy and payer relationships develop.
A detailed project report or DPR typically includes promoter background, specialty-specific revenue projections, phase-specific capital deployment, multi-year financials with DSCR, land/construction and equipment quotations, and evidence of regulatory approval progress (Clinical Establishment registration, fire NOC, biomedical waste authorization, and similar).